Free Trial

Panbela Therapeutics (PBLA) SEC Filings & 10K Form

Panbela Therapeutics logo
$0.26 +0.00 (+1.81%)
As of 04/30/2025 03:44 PM Eastern

Recent Panbela Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2025
7:02 PM
Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
Form SCHEDULE 13D/A
02/04/2025
3:02 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:02 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:50 PM
Panbela Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/19/2024
5:40 PM
Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:59 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:00 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:01 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:02 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:03 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:04 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:05 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
3:16 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
5:00 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:15 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:03 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:06 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:09 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:12 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:12 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
6:40 PM
Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
Form SC 13D
10/29/2024
6:38 PM
Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2024
8:24 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:24 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:25 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:25 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:26 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:26 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:27 AM
Panbela Therapeutics (Filer)
Form 424B3
10/28/2024
4:16 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:26 PM
Horvath Susan (Reporting)
Panbela Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:34 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:25 PM
Panbela Therapeutics (Filer)
Form S-1/A
08/13/2024
7:39 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:40 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:42 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:43 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:45 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:46 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:47 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
4:08 PM
Panbela Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
07/30/2024
4:30 PM
Panbela Therapeutics (Filer)
Form 424B3
07/30/2024
3:59 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
3:46 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:00 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:21 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:22 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:24 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:27 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:29 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
3:16 PM
Panbela Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PBLA) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners